We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Nastech to Host Webinar on its RNAi Therapeutics Programs and siRNA Delivery Technology

Read time: Less than a minute

Nastech Pharmaceutical Company Inc. has announced that it will host a Webinar concerning its emerging siRNA therapeutics programs and siRNA drug delivery technology. Steven C. Quay, M.D., Ph.D., Chairman, President and CEO will present at the event.

What: RNAi webinar on the science and business of RNAi therapeutics followed by a Q&A session. Questions may be emailed in advance to [email protected] or during the event through the webinar interface
             
When: Thursday, November 9, 2006, from 10:30-11:15 AM U.S. East Coast time

How: Live over the Internet FREE via a simple advanced registration online
 
Where: Webinar will be available online. once you are registered

If you are unable to participate during the live RNAi webinar webcast, an archive and replay will be available for 30 days via Nastech's website.

During the webinar, Dr. Quay will provide an overview of the exciting science behind RNAi and discuss the Company's rheumatoid arthritis and influence therapeutics programs as well as the Company's molecular biology based drug delivery technology.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.